Oral incretin pill shows measurable weight and glycaemic benefits Recent clinical trial reports indicate that a new oral glucagon‑like peptide‑1 (GLP‑1) agent produced clinically meaningful benefits for people taking it in trial settings. Participants experie…
Recent clinical trial reports indicate that a new oral glucagonlike peptide1 (GLP1) agent produced clinically meaningful benefits for people taking it in trial settings. Participants experienced aver… [+1621 chars]
